Skip to main content

GSK · GSK plc · Investor Relations

Track GSK — free
$48.58 -0.66 (-1.34%) At close · Nov 18 Q3 2026 earnings call transcript
Market Cap
$97.38B
Shares
2.00B
Volume · Nov 18 2.2M Avg daily vol (3M) 4.03M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-12-01 15:00 UTC CONFERENCE Conference
2026-12-03 00:00 UTC CONFERENCE Conference
2027-01-12 00:00 UTC CONFERENCE Conference
2027-02-03 00:00 UTC QUARTERLY RESULTS Results publication
2027-02-03 00:00 UTC We will announce our full year and fourth quarter results on Wednesday, 3 February 2027. Results publication

Past events

Date Event Type
2026-11-17 CONFERENCE Conference
2026-11-10 CONFERENCE Conference
2026-10-28 We will announce our third quarter results on Wednesday, 28 October 2026. Results publication
2026-10-28 QUARTERLY RESULTS Earnings call
2026-10-27 INVESTOR BRIEFING Webcast
2026-09-23 Julie Brown, Chief Financial Officer, will attended and take part in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 23 September 2026. Conference
2026-09-23 Julie Brown, Chief Financial Officer, will attend and take part in a fireside chat at the BofA Global Healthcare Conference in London on Wednesday, 23 September 2026. Conference
2026-09-15 Hesham Abdullah, SVP, Global Oncology R&D, will participate at the Morgan Stanley’s 24th Annual Global Healthcare Conference in New York on Tuesday, 15 September 2026. Conference
2026-09-09 Julie Brown, Chief Financial Officer, will attended and take part in a fireside chat at the Bernstein’s 23rd Annual Pan-European Strategic Decisions Conference in London on Wednesday, 9 September 2026. Conference
2026-07-28 Q2 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-04-29 Q1 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-02-04 FY & Q4 2025 results Earnings call

Source: https://www.gsk.com/en-gb/company/governance/shareholders/

Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 922 filings 845 filers Visit website Investor relations